- Home
- BJDX vs NDRA Comparison
BJDX vs NDRA Comparison
Compare BJDX & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BJDX
- NDRA
- Stock Information
- Founded
- BJDX 2015
- NDRA 2007
- Country
- BJDX United States
- NDRA United States
- Employees
- BJDX N/A
- NDRA N/A
- Industry
- BJDX Medical Specialities
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BJDX Health Care
- NDRA Health Care
- Exchange
- BJDX Nasdaq
- NDRA Nasdaq
- Market Cap
- BJDX 2.2M
- NDRA 2.1M
- IPO Year
- BJDX 2021
- NDRA 2017
- Fundamental
- Price
- BJDX $1.67
- NDRA $3.98
- Analyst Decision
- BJDX
- NDRA Strong Buy
- Analyst Count
- BJDX 0
- NDRA 1
- Target Price
- BJDX N/A
- NDRA $50.00
- AVG Volume (30 Days)
- BJDX 3.4M
- NDRA 355.0K
- Earning Date
- BJDX 05-14-2025
- NDRA 05-13-2025
- Dividend Yield
- BJDX N/A
- NDRA N/A
- EPS Growth
- BJDX N/A
- NDRA N/A
- EPS
- BJDX N/A
- NDRA N/A
- Revenue
- BJDX N/A
- NDRA N/A
- Revenue This Year
- BJDX N/A
- NDRA N/A
- Revenue Next Year
- BJDX $55.56
- NDRA N/A
- P/E Ratio
- BJDX N/A
- NDRA N/A
- Revenue Growth
- BJDX N/A
- NDRA N/A
- 52 Week Low
- BJDX $1.48
- NDRA $2.97
- 52 Week High
- BJDX $316.80
- NDRA $665.00
- Technical
- Relative Strength Index (RSI)
- BJDX 38.27
- NDRA 51.65
- Support Level
- BJDX $1.46
- NDRA $3.28
- Resistance Level
- BJDX $3.60
- NDRA $3.98
- Average True Range (ATR)
- BJDX 0.63
- NDRA 0.92
- MACD
- BJDX -0.13
- NDRA 0.02
- Stochastic Oscillator
- BJDX 2.40
- NDRA 31.76
About BJDX Bluejay Diagnostics Inc.
Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.